CLC Number:
- R473.73
| [1] 孔胜男, 余智操, 张琼,等. 肿瘤免疫检查点抑制剂的心脏不良反应及管理策略[J]. 中国免疫学杂志, 2019, 35(12): 1514-1517. DOI:10.3969/j.issn.1000-484X.2019.12.022. [2] Zhou YW, Zhu YJ, Wang MN, et al.Immune checkpoint inhibitor-associated cardiotoxicity: current understanding on its mechanism,diagnosis and management[J].Front Pharmacol, 2019,29(10):1350. [3] Chen DY, Huang WK, Wu VCC, et al.Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: a review when cardiology meets immuno-oncology[J]. J Formos Med Assoc, 2020, 119(10):1461-1475. [4] Salem JE, Manouchehri A, Moey M, et al.Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study[J]. Lancet Oncol, 2018, 19(12):1579-1589. [5] 宋彦君. 免疫检查点抑制剂相关心肌炎及主要心血管事件对预后的影响[D].北京:北京协和医学院, 2022. DOI: 10.27648/d.cnki.gzxhu.2022.000710. [6] 王伟铭, 陈洪宇, 刘华锋, 等. 糖皮质激素常见副作用的中西医结合治疗[J]. 中华肾病研究电子杂志, 2015, 4(4): 173-176. DOI:10.3877/cma.j.issn.2095-3216.2015.04.002. [7] 崔赢, 栾兰, 黄瑞. 静脉输注人免疫球蛋白不良反应的临床特点[J]. 实用药物与临床,2015,18(12):1490-1493. DOI: 10. 14053 /j. cnki. ppcr. 201512026. [8] Wang DY, Salem JE, Cohen JV, et al.Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and Meta-analysis[J]. JAMA Oncol, 2018, 4(12): 1721-1728. [9] 中华医学会心血管病学分会精准医学学组,中华心血管病杂志编辑委员会,成人暴发性心肌炎工作组. 成人暴发性心肌炎诊断与治疗中国专家共识[J]. 中华心血管病杂志,2017,45(9):742-752.DOI:10.3760/cma.j.issn.0253-3758.2017.09.004. |
| [1] | CAO Min, ZHANG Pei-li, HOU Xiao-ya, GAO Chao-yue, GUO Lin-fang, LI Ying. Nutritional care experience of caregivers of colorectal cancer patients undergoing chemotherapy based on ABC-X model: a qualitative study [J]. Journal of Nursing, 2025, 32(2): 13-18. |
| [2] | LIU Qi, LIU Jia-li, LIU Yu, YANG Li-min, FAN Yu-ying, LV Xing, JIN Hui-ying. Physical-psychological symptom burden trajectories and influencing factors in nasopharyngeal carcinoma patients during induction chemotherapy plus concurrent chemoradiotherapy [J]. Journal of Nursing, 2025, 32(1): 1-6. |
| [3] | . [J]. Journal of Nursing, 2025, 32(1): 39-43. |
| [4] | YAO Wan-qing, YANG Li-zhuang, CHEN Dan-dan, ZHANG Wan-qiu, LU Wei, GUAN Cui-hong, LI Hai. Efficacy of different non-drug interventions on cancer-related fatigue in breast cancer patients: a network Meta-analysis [J]. Journal of Nursing, 2024, 31(24): 37-43. |
| [5] | DAI Qian, LIU Xiang-yu, ZHU Xiao-mei, WANG Jia-li, HUANG Yuan-si. Status quo of self-compassion in patients with colorectal cancer stoma and its influencing factors [J]. Journal of Nursing, 2024, 31(23): 13-17. |
| [6] | . [J]. Journal of Nursing, 2024, 31(22): 73-78. |
| [7] | LI Yue-ge, KONG Han, CAO Ding, LI Jia-xin, SHANG Ya-meng, CHANG Shu-ying. Current status of fear of cancer recurrence in young and middle-aged patients with cervical cancer after surgery and its influencing factors: a 228-case study [J]. Journal of Nursing, 2024, 31(20): 8-12. |
| [8] | . [J]. Journal of Nursing, 2024, 31(20): 19-23. |
| [9] | . [J]. Journal of Nursing, 2024, 31(20): 29-32. |
| [10] | . [J]. Journal of Nursing, 2024, 31(18): 30-34. |
| [11] | GENG Yu-fang, QIN Ru-meng, WANG Hui, ZHANG Shan-shan, ZHOU Li-hua. Construction of post-traumatic growth model of ovarian cancer patients based on interpretative phenomenological analysis [J]. Journal of Nursing, 2024, 31(18): 73-78. |
| [12] | . [J]. Journal of Nursing, 2024, 31(17): 51-56. |
| [13] | YU Feng, SUN Li, HU De-ying, HU Jie, WANG Jia-qing, LV Chu-feng. Competency model of suicide gatekeeper for oncology nurses based on behavioral event interview and expert consultation [J]. Journal of Nursing, 2024, 31(17): 73-78. |
| [14] | . [J]. Journal of Nursing, 2024, 31(16): 56-61. |
| [15] | ZHANG Shu-zhen, YU Wen-ru, ZHANG Jun-feng, JIANG Jia-yao, LUO Mei, LIN Bi-yu, MAI Min-wen, YANG Meng-ting. Evidence-based nursing practice in prevention and management of radiation dermatitis in cancer patients undergoing radiotherapy [J]. Journal of Nursing, 2024, 31(16): 62-66. |
|
||